TITLE

Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome

AUTHOR(S)
Koutsopoulos, Olga S; Kretz, Christine; Weller, Claudia M; Roux, Aurelien; Mojzisova, Halina; Böhm, Johann; Koch, Catherine; Toussaint, Anne; Heckel, Emilie; Stemkens, Daphne; ter Horst, Simone A J; Thibault, Christelle; Koch, Muriel; Mehdi, Syed Q; Bijlsma, Emilia K; Mandel, Jean-Louis; Vermot, Julien; Laporte, Jocelyn
PUB. DATE
June 2013
SOURCE
European Journal of Human Genetics;Jun2013, Vol. 21 Issue 6, p637
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Heterozygous mutations in dynamin 2 (DNM2) have been linked to dominant Charcot-Marie-Tooth neuropathy and centronuclear myopathy. We report the first homozygous mutation in the DNM2 protein p.Phe379Val, in three consanguineous patients with a lethal congenital syndrome associating akinesia, joint contractures, hypotonia, skeletal abnormalities, and brain and retinal hemorrhages. In vitro membrane tubulation, trafficking and GTPase assays are consistent with an impact of the DNM2p.Phe379Val mutation on endocytosis. Although DNM2 has been previously implicated in axonal and muscle maintenance, the clinical manifestation in our patients taken together with our expression analysis profile during mouse embryogenesis and knockdown approaches in zebrafish resulting in defects in muscle organization and angiogenesis support a pleiotropic role for DNM2 during fetal development in vertebrates and humans.
ACCESSION #
87598064

 

Related Articles

  • Myotonia in DNM2-related centronuclear myopathy. Dabby, Ron; Sadeh, Menachem; Gilad, Ronit; Jurkat-Rott, Karin; Lehmann-Horn, Frank; Leshinsky-Silver, Esther // Journal of Neural Transmission;May2014, Vol. 121 Issue 5, p549 

    Centronuclear myopathy (CNM) is a rare hereditary myopathy characterized by centrally located muscle fiber nuclei. Mutations in the dynamin 2 ( DNM2) gene are estimated to account for about 50 % of CNM cases. Electromyographic recordings in CNM may show myopathic motor unit potentials without...

  • Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China. Chen, Ting; Pu, Chuanqiang; Wang, Qian; Liu, Jiexiao; Mao, Yanling; Shi, Qiang // Neurological Sciences;May2015, Vol. 36 Issue 5, p735 

    Mutations in the dynamin-2 ( DNM2) gene can cause autosomal dominant or sporadic centronuclear myopathy (CNM). We aimed to analyze the clinical, pathological and genetic characteristic of patients with DNM2-related CNM in China. We studied seven patients, all of whom underwent clinical...

  • Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy. XINHONG LIU; HUAMIN WU; JIAN GONG; TAO WANG; CHUANZHU YAN // Molecular Medicine Reports;2016, Vol. 13 Issue 5, p4273 

    The aim of the present study was to report on a family with pathologically and genetically diagnosed autosomal dominant inherited centronuclear myopathy (CNM). In addition, this study aimed to investigate the clinical, pathological and molecular genetic characteristics of the disease. This...

  • Clinical utility gene card for: Centronuclear and myotubular myopathies. Biancalana, Valérie; Beggs, Alan H; Das, Soma; Jungbluth, Heinz; Kress, Wolfram; Nishino, Ichizo; North, Kathryn; Romero, Norma B; Laporte, Jocelyn // European Journal of Human Genetics;Oct2012, Vol. 20 Issue 10, p1 

    The article offers information on the genetic aspects of centronuclear and myotubular myopathies. It discusses the different genes or DNA/chromosome segments of the said myopathies, which include myotubular myopathy 1 (MTM1), dynamin 2 (DNM2), and ryanodine receptor 1 (RYR1). It says that de...

  • Dynamin 2 mutations in Charcot–Marie–Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination. Sidiropoulos, Páris N. M.; Miehe, Michaela; Bock, Thomas; Tinelli, Elisa; Oertli, Carole I.; Kuner, Rohini; Meijer, Dies; Wollscheid, Bernd; Niemann, Axel; Suter, Ueli // Brain: A Journal of Neurology;May2012, Vol. 135 Issue 5, p1395 

    Mutations in dynamin 2 (DNM2) lead to dominant intermediate Charcot–Marie–Tooth neuropathy type B, while a different set of DNM2 mutations cause autosomal dominant centronuclear myopathy. In this study, we aimed to elucidate the disease mechanisms in dominant intermediate...

  • Dynamin 2 the rescue for centronuclear myopathy. Demonbreun, Alexis R.; McNally, Elizabeth M. // Journal of Clinical Investigation;Mar2014, Vol. 124 Issue 3, p976 

    Centronuclear myopathy is a lethal muscle disease. The most severe form of the disease, X-linked centronuclear myopathy, is due to mutations in the gene encoding myotubularin (MTM1), while mutations in dynamin 2 (DNM2) and amphiphysin 2/BIN1 (AMPH2) cause milder forms of myopathy. MTM1 is a...

  • Centronuclear Myopathy in Labrador Retrievers: A Recent Founder Mutation in the PTPLA Gene Has Rapidly Disseminated Worldwide. Maurer, Marie; Mary, Jérôme; Guillaud, Laurent; Fender, Marilyn; Pelé, Manuel; Bilzer, Thomas; Olby, Natasha; Penderis, Jacques; Shelton, G. Diane; Panthier, Jean-Jacques; Thibaud, Jean-Laurent; Barthélémy, Inès; Aubin-Houzelstein, Geneviève; Blot, Stéphane; Hitte, Christophe; Tiret, Laurent // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Centronuclear myopathies (CNM) are inherited congenital disorders characterized by an excessive number of internalized nuclei. In humans, CNM results from ~70 mutations in three major genes from the myotubularin, dynamin and amphiphysin families. Analysis of animal models with altered expression...

  • Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy. Ning Liu; Bezprozvannaya, Svetlana; Shelton, John M.; Frisard, Madlyn I.; Hulver, Matthew W.; cMillan, Ryan P.; Wu, Yaru; Voelker, Kevin A.; Grange, Robert W.; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.; Liu, Ning; McMillan, Ryan P // Journal of Clinical Investigation;Aug2011, Vol. 121 Issue 8, p3258 

    MicroRNAs modulate cellular phenotypes by inhibiting expression of mRNA targets. In this study, we have shown that the muscle-specific microRNAs miR-133a-1 and miR-133a-2 are essential for multiple facets of skeletal muscle function and homeostasis in mice. Mice with genetic deletions of...

  • Genetic neuromuscular disease. Reilly, Mary M.; Hanna, Michael G. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2002 Supplement 2, Vol. 73, pII12 

    In this article, the authors discuss various common genetic peripheral nerve and genetic muscle diseases in terms of latest genetic information and DNA based diagnosis. Classification and diagnosis of disorders such as Charcot-Marie-Tooth diseases and muscular dystrophies are given. They suggest...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics